Michael S. Aberman, SVP Strategy Investor Relation at REGENERON PHARMACEUTICALS INC (REGN), sold 7,500 shares at $462.84 ($3.5M) on 2015-03-18, disclosed to the SEC on 2015-03-19.
Scheduled sale ($3.5M) by SVP Strategy Investor Relation under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $457.91 | 3,665 | $1.7M | 48.5% |
| 2 | $457.91 | 393 | $180K | 5.2% |
| 3 | $462.84 | 400 | $185K | 5.4% |
| 4 | $463.60 | 1,500 | $695K | 20.1% |
| 5 | $464.44 | 500 | $232K | 6.7% |
| 6 | $465.42 | 500 |
| $233K |
| 6.7% |
| 7 | $468.92 | 100 | $47K | 1.4% |
| 8 | $469.68 | 100 | $47K | 1.4% |
| 9 | $470.97 | 142 | $67K | 1.9% |
| 10 | $471.24 | 100 | $47K | 1.4% |
| 11 | $472.14 | 100 | $47K | 1.4% |
| Total | $461.17 avg | 7,500 | $3.5M | 100% |
| Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |
| REGN | SELL | 2014-08-19 | $1.3M | — | Filing → |